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Background: Allergic reactions to plant and animal derived food allergens can have serious consequences for
sufferers and their families. The associated social, emotional and financial costs make it a priority to understand the best
ways of managing such immune-mediated hypersensitivity responses. Conceptually, there are two main approaches to
managing food allergy: those targeting immediate symptoms and those aiming to support long-term management of
the condition. The European Academy of Allergy and Clinical Immunology is developing guidelines about what
constitutes an effective treatment for food allergies. As part of the guidelines development process, a systematic review
is planned to examine published research about the management of food allergy in adults and children.
Methods: Seven bibliographic databases were searched from their inception to September 30, 2012 for systematic
reviews, randomized controlled trials, quasi-randomized controlled trials, controlled clinical trials, controlled
before-and-after studies and interrupted time series. Experts were consulted for additional studies. There were no
language or geographic restrictions. Studies were critically appraised using the Critical Appraisal Skills Program and
Cochrane EPOC Risk of Bias tools. Only studies where people had a diagnosis of food allergy or reported a history of
food allergy were included. This means that many studies of conditions that may be caused by food allergy are
omitted, because only research in people with an explicit diagnosis or history was eligible.
Discussion: Many initiatives have been tested to treat the immediate symptoms of food allergy (acute management)
and to deal with longer lasting symptoms or induce tolerability to potential allergens (long-term management). The
best management strategies for people with food allergy are likely to depend on the type of allergy, symptom
manifestations and age. There is a real need to increase the amount of high quality research devoted to treatment
strategies for food allergy. Food allergy can be debilitating and is affecting an increasing number of children and
adults. With such little known about how to effectively manage the condition and its manifestations, this appears a
priority for future research.
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Recent estimates suggest that around 17 million people
in Europe suffer from allergies triggered by foods such
as milk, eggs, peanuts, tree nuts or seafood, and an
increasing number are seeking treatment through
primary care and hospital emergency departments [1].
Food allergies can have a significant effect on people’s
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reproduction in any medium, provided the orcostly in terms of medical visits and treatments [1]. With
such high social and economic costs, it is important to
ensure that effective, evidence-based treatments are
available.
The European Academy of Allergy and Clinical
Immunology (EAACI) is developing guidelines about
what constitutes an effective treatment. As part of the
guidelines development process, a systematic review is
planned to examine published research about the
management of food allergy in adults and children.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Potential manifestations of food allergy eligible
for inclusion
Pathology Disorder
IgE-mediated (acute-onset) Acute urticaria/angioedema
Contact urticaria
Oral allergy syndrome
(pollen-associated food
allergy syndrome)
Allergic asthma/wheeze
Atopic eczema/dermatitis
Immediate gastrointestinal
hypersensitivity such as
vomiting and diarrhoea
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The aims of this systematic review will be to:
 examine what pharmacological and non-
pharmacological interventions have been researched
to manage the symptoms of food allergy in
individuals (i.e. acute treatment)
 examine what pharmacological and non-
pharmacological interventions have been researched to
manage longer-term outcomes in individuals such as
tolerance and coping (i.e. longer-term management)
 where possible, quantify the extent to which such
approaches may be effective.Cell-mediated (delayed onset/chronic) Food protein induced
gastroenteropathy
Food protein-induced
enterocolitis syndrome
Food protein-induced
allergic proctocolitis
Atopic eczema/dermatitis
Allergic contact dermatitis
Heiner syndrome
Combined IgE and cell-mediated
(delayed onset/chronic)
Atopic eczema/dermatitis
Eosinophilic esophagitis
Eosinophilic gastroenteritis
Food allergy is complex and may manifest as other pathologies. As well as
food allergy per se, studies of the following pathologies are eligible for
inclusion, as long as there is suspicion of food allergy and the intervention
focuses on addressing dietary or food-related issues. Coeliac disease is an
important non-IgE mediated condition but as it has distinct symptoms and
prognosis different from atopic conditions it will be excluded from this review.Scope
The umbrella term ‘food hypersensitivity’ is used to
describe any adverse reaction to food [2]. The term
‘food allergy’ refers to the subgroup of food-triggered
reactions in which immunological mechanisms have been
implicated, whether IgE-mediated, non-IgE-mediated, or
involving a combination of IgE- and non-IgE-mediated
etiologies [3]. All other reactions to food that have
sometimes been referred to as ‘food intolerance’ constitute
non-allergic food hypersensitivity reactions and are outside
the focus of this enquiry.
The topic of food allergy is complicated, however, by
the fact that IgE-mediated reactions can manifest as
angioedema, urticaria, atopic eczema/dermatitis, oral
allergy syndrome and anaphylaxis, for example. Non-
IgE-mediated immunological reactions result from
activation of other immunological pathways (e.g. T-cell
mediated) and can manifest as atopic eczema/dermatitis,
gastro-esophageal reflux disease, food protein-induced
enterocolitis, proctocolitis and enteropathy syndromes.
The contemporary definition of food allergy thus includes
several clinical entities with different pathophysiologies
resulting from exposure to different foods [4]. Table 1 lists
the potential manifestations of food allergy included in
the review.
The clinical management of food allergy includes
strategies to minimise the risk of further reactions,
primarily through education and behavioural approaches
to avoid allergens and dietary modification, and approaches
to improve outcomes if a further reaction does occur
through pharmacological and non-pharmacological
management strategies. There is also growing interest
in the effectiveness of potential immuno-modulatory
treatment approaches, including sublingual and oral
immunotherapy [2]. The review will synthesise evidence
about the effectiveness of these management approaches
for individuals. Interventions at a community, organisa-
tional or societal level, such as food labeling or regulation,
will not be included.The EAACI is in the process of developing the EAACI
Guideline for Food Allergy and Anaphylaxis, and this
systematic review is one of seven inter-linked evidence
syntheses that are being undertaken in order to provide
a state-of-the-art synopsis of the current evidence base
in relation to epidemiology, prevention, diagnosis and
clinical management, and impact on quality of life, which
will be used to inform clinical recommendations.
Methods
Inclusion criteria
We have conceptualised the review to incorporate the
interventions, study designs and outcomes, as shown in
Figure 1: Conceptualisation of systematic review on the
management of food allergy.
Study designs eligible for inclusion in the review
comprise:
 systematic reviews with or without meta-analyses
 randomised controlled trials
 quazi-randomised controlled trials and controlled
clinical trials (defined as studies where the
comparison group is not fully randomised)
Figure 1 Conceptualisation of systematic review on the management of food allergy.
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clearly defined comparison group is available
prospectively) and interrupted time series studies
(where measures are taken during at least three
timepoints before and at least three time points after
intervention).
We suspect that there will be limited information
available from systematic reviews and randomised trials,
so we have opted to incude lower forms of evidence
where non-random allocation of patients has occurred
[5]. Studies already included in other systematic reviews
will also be eligible for quality appraisal and inclusion in
this review. Only research published as full papers will
be eligible for inclusion. Where repeated reports of the
same study are identified, the most up-to-date or detailed
will be included.
Exclusion criteria
The following material will be excluded from the review:
 non-systematic reviews, discussion papers, non-
research letters and editorials
 qualitative studies
 case studies, case series, non controlled before and
after studies and other lower quality designs
 animal studies
 abstracts and studies not available in full form
 unpublished material
 studies about anaphylaxis (as these are covered in
another review in the series).Search strategy
We will search the following databases:
 Cochrane Library, including:
○ Cochrane Database of Systematic Reviews
(CDSR)
○ Database of Reviews of Effectiveness (DARE)
○ CENTRAL (Trials)
○ Methods Studies
○ Health Technology Assessments (HTA)
○ Economic Evaluations Database (EED)
 MEDLINE (OVID)
 Embase(OVID)
 CINAHL (Ebscohost)
 ISI Web of Science (Thomson Web of Knowledge)
 TRIP Database (www.tripdatabase.com)
 Clinicaltrials.gov (NIH web)
A highly sensitive search strategy has been developed,
and validated study design filters will be applied to
retrieve all articles pertaining to the management of food
allergy from electronic bibliographic databases.
To retrieve systematic reviews, we will use the systematic
review filter developed at McMaster University Health
Information Research Unit (HIRU) [6].
To retrieve randomised controlled trials, we will apply
the Cochrane highly sensitive search strategy for identifying
randomised trials in MEDLINE: sensitivity- and precision-
maximising version (2008 revision); Ovid format from
Chapter 6 of the Cochrane Handbook [7]. To retrieve
non-randomised studies such as interrupted time-series
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controlled clinical trials (CCT), we will use the Cochrane
Effective Practice and Organisation of Care (EPOC) filter
Version 2.4 from the EPOC Group [8,9].
The search strategy has been developed on OVID
MEDLINE and then adapted for the other databases (see
Additional file 1 for full search strategies). In all cases
the databases will be searched from inception to 30
September 2012. All references will be imported into an
EndNote Library and tagged with the name of the database.
Additional references will be located through searching
the references cited in identified reviews and contacting
experts in the field.
We will invite experts who are active in the field from
a range of disciplines and geography to comment on our
search strategy, and the list of included studies. No
language restrictions will be applied and, where possible,
all literature will be translated.
Study selection
Identified titles will be checked independently by two
reviewers according to the above selection criteria and
categorised as: included, not included and unsure. For
those papers in the unsure category, we will retrieve the
abstract and re-categorise as above. Any discrepancies
will be resolved by consensus and if necessary a third
reviewer will be consulted. Full text copies of potentially
relevant studies will be obtained and their eligibility for
inclusion independently assessed. Studies that do not
fulfil all of the inclusion criteria will be excluded.
Quality assessment strategy
Quality assessments will independently be carried out
on each study by two reviewers. Systematic reviews will be
assessed for quality using the relevant Critical Appraisal
Skills Programme Tool (CASP) [10]. We will assess the
risk of bias of studies eligible for the review using the
criteria suggested by EPOC [11]. Randomised controlled
trials, controlled clinical trials and controlled before and
after studies will be assessed for generation of allocation
sequence, concealment of allocation, baseline outcome
measurements, baseline characteristics, incomplete
outcome data, blinding of outcome assessor, protection
against contamination, selective outcome reporting and
other risks of bias. For interrupted time series designs we
will also assess the independence of the intervention from
other changes, the pre-specified shape of the intervention
and whether the intervention was likely to affect data
collection. Our quality assessments will draw on the
principles incorporated into the Cochrane EPOC Group
guidelines for assessing intervention studies [12] and the
Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) for assessing observational
studies [13].Analysis, data synthesis and reporting
Data will be independently extracted onto a customised
data extraction sheet by two reviewers, and any discrepan-
cies will be resolved by discussion or, if agreement cannot
be reached, by arbitration by a third reviewer.
A descriptive summary with data tables will be produced
to summarise the literature. A narrative synthesis of the
data will be undertaken. If clinically and statistically
appropriate, meta-analysis using either fixed-effect or
random-effects modelling may be undertaken for poten-
tially useful interventions using methods suggested by
Agresti and Coul [14].
This review has been registered with the International
Prospective Register of Systematic Reviews (PROSPERO)
and has registration number CRD42013003708 allocated
to it. The Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) checklist will be
used to guide the reporting of the systematic review [15].Discussion
Many initiatives have been tested to treat the immediate
symptoms of food allergy (acute management) and to
deal with longer lasting symptoms or induce tolerability
to potential allergens (long-term management). The best
management strategies for people with food allergy are
likely to depend on the type of allergy, symptom mani-
festations and age. In terms of acute management, there
is little evidence to help differentiate the most effective
treatments. Regarding long-term management, avoiding
the culprit food or substituting an alternative is likely to
be of benefit. Other management strategies include
alternatives to cow’s milk formula to reduce symptoms
in infants with cow’s milk allergy, supplements such as
probiotics and allergen-specific immunotherapy. Most
importantly, this review will help to synthesis the highest
levels of evidence pertaining to treatment strategies for
food allergy and identify any gaps in our knowledge. Food
allergy can be debilitating and is affecting an increasing
number of children and adults. With such little known
about how to effectively manage the condition and its
manifestations, this appears a priority for future research.Additional file
Additional file 1: Search strategies.
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